Background-Coeliac women may suffer from gynaecological and obstetric complications. It is possible that these complications are the first symptom of coeliac disease. Aims-To investigate the occurrence of subclinical coeliac disease in patients with infertility or recurrent miscarriages. Subjects 
The classic symptoms of coeliac disease are diarrhoea and malabsorption. Nowadays, however, many patients have only subtle manifestations, and the disease may even be silent, with no symptoms at all. ' Some coeliac patients present with atypical non-abdominal symptoms. Such clinically silent or atypical forms of the disorder can be detected using reticulin, endomysium, and gliadin antibody tests as screening methods. 2 3 Many studies have shown that coeliac women are susceptible to reproductive difficulties such as infertility and miscarriages.6 There are no reports, however, on the occurrence of silent coeliac disease among patients with reproductive disorders. In this study we applied serological screening tests to detect coeliac disease among women suffering from infertility or miscarriages. Accepted for publication 9 May 1996 resulted in a cut off level of IgA class gliadin antibodies at 0.20 EU/ml. This cut off level finds childhood and adolescent coeliac disease at a rate of 90% but gives at the same time 30% positive results in subjects with normal jejunal mucosa.'0 Patients positive in one or both of these screening tests underwent upper gastrointestinal endoscopy, including biopsy specimens taken from the descending part of the duodenum. The diagnosis of coeliac disease was based on subtotal or severe partial small bowel villous atrophy and crypt hyperplasia on duodenal biopsy. Women having villous atrophy started a gluten free diet. A control biopsy specimen was taken after they had maintained a gluten free diet for six to 12 months.
The study protocol was approved by the ethics committee of the University Hospital of Tampere.
Results Four (2.7%) of 150 women in the infertility group, and none in the control group were found to have coeliac disease (p=006) ( Table I ). All women with coeliac disease were categorised in the group of unexplained infertility. Thus, in this subgroup coeliac disease was detected in four (4. 1%) of 98 women. The difference from the control group (none of 150) was statistically significant, p=0.02. No coeliac disease was detected among 29 women with tubal infertility, 23 with hormonal infertility, and 50 women with miscarriages.
Of the four women with coeliac disease, two had iron deficiency anaemia, but no apparent gastrointestinal symptoms; two women had asymptomatic coeliac disease (Table II) . None had folic acid deficiency. Their mean (SD) age at menarche was 14.7 (1-5) years. All four started gluten free diet, and the control biopsy showed mucosal recovery in every one. Two patients have conceived during the follow up, one at the time she was starting the gluten free diet, the outcome of pregnancy being normal, and the other had had one unsuccessful 'in vitro fertilisation and embryo transfer' (IVF-ET) earlier while on a normal diet. She conceived with IVF-ET, after being on six months of gluten free diet. She had, however, to have induced abortion due to fetal malformation.
All four women with coeliac disease had gliadin and three had reticulin antibodies. Normal small bowel mucosa despite positive gliadin antibodies was found in six women with infertility, in two with spontaneous abortions, and in two women undergoing sterilisation. One woman in the control group had positive reticulin antibodies, but normal small bowel mucosa.
Discussion
This study shows that some women suffering from unexplained infertility have clinically silent coeliac disease. The observed frequency of 4.1% is at least 10 times higher than the prevalence of coeliac disease in the population. According to population screening studies, the estimated prevalence figure for 
